Current developments in gene therapy for epidermolysis bullosa.
Thomas KocherIgor PetkovicJohannes BischofUlrich KollerPublished in: Expert opinion on biological therapy (2022)
-splicing or short antisense oligonucleotides, especially designer nucleases, have steadily improved in efficiency and safety and thus likely represent the most promising gene therapy tool in the near future.